Supplementary_material__Quality_assessment__before-after_studies_OMA-QoL – Supplemental material for Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review

Supplemental material, Supplementary_material__Quality_assessment__before-after_studies_OMA-QoL for Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review by Giorgio Lorenzo Colombo, Sergio Di Matteo, Chiara Martinotti, Martina Oselin, Maria Chiara Valentino, Giacomo Matteo Bruno, Claudia Pitotti and Francesco Menzella in Therapeutic Advances in Respiratory Disease